The use of a dynamic contrast (gadolinium)-enhanced T2-weighted MRI (DCE-MRI)appears to be a very promising new means of detecting prostate cancer lesions,according to a National Cancer Institute-funded study.
From evidence to practice: Dr. Makarov discusses implementation science in urology
July 25th 2024“What our major contribution is, I think as urologists doing implementation science, is determining the important questions, which we are particularly well-suited to do because we're taking care of the patients,” says Danil V. Makarov, MD, MHS.